- Image via Wikipedia
WASHINGTON, D.C. – The U.S. Food and Drug Administration has approved four vaccines to guard against the H1N1 flu virus – and there will be enough doses to go around, Reuters reported Tuesday.
Health and Human Services Secretary Kathleen Sebelius announced the approval at a hearing of the House Energy and Commerce Committee.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“There will be vaccines for everyone,” Sebelius said, according to Reuters.
The vaccines that have gotten the green light are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited and Sanofi Pasteur Inc., according to a statement issued by the FDA.
Sebelius said the government has ordered 195 million doses but may order more if necessary, the Associated Press reported.
On Sunday, Sebelius told ABC that the first vaccines – intended for health care workers and other high-risk groups, including pregnant women – may be available the first week of October. About 45 million doses are expected by the middle of next month.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Preliminary data from studies of the vaccines have shown that a single dose will “induce a robust immune response in most healthy adults” after eight to 10 days, according to the FDA. Studies to determine the “optimal dose” for children are underway, the federal agency said.
More stories worth a read:
- Cleveland Clinic’s air medical service has reached patients in 31 states and 11 countries (Cleveland Plain Dealer)
- Job-based health insurance: Costs climb at a moderate pace (Health Affairs)
- Obama seeks support from labor for health overhaul (Wall Street Journal)
- Pervasis Therapeutics secures $10M in new financing (Xconomy | Boston)
- Collaboration of Ohio agencies, hospitals, other groups reduces scheduled preterm births (Cleveland Plain Dealer)
- From the osteoporosis front, updates on potential new drugs (Wall Street Journal)
- University of Akron breaks ground for $13 million polymer center (Crain’s Cleveland Business)
- Diabetes medication may get new life as cancer treatment (Wall Street Journal)
- Medtronic loses $30 million insulin pump suit against Nova Biomedical (MassDevice)
